Naloxone-Induced Acute Opioid Withdrawal in a Stabilized Extended-Release Naltrexone-Treated Patient

Prim Care Companion CNS Disord. 2020 Sep 17;22(5):20l02590. doi: 10.4088/PCC.20l02590.

Authors

Andrew J Spitzberg^{1

2}, Edith M Urner³, William C Wirshing^{3

4}

Affiliations

¹ Keck School of Medicine of USC, 1975 Zonal Ave, Los Angeles, CA 90033. Aspitzberg@northwell.edu.
² Keck School of Medicine of USC, Los Angeles, California, USA.
³ Exodus Recovery Inc., Los Angeles, California, USA.
⁴ Department of Psychiatry, Keck School of Medicine of USC, Los Angeles, California, USA.

PMID: 32942347
DOI: 10.4088/PCC.20l02590

No abstract available

MeSH terms

Analgesics, Opioid / adverse effects
Humans
Naloxone / therapeutic use
Naltrexone* / adverse effects
Narcotic Antagonists / adverse effects
Substance Withdrawal Syndrome* / drug therapy
Substance Withdrawal Syndrome* / etiology

Substances

Analgesics, Opioid
Narcotic Antagonists
Naloxone
Naltrexone